Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • CHOP Researchers Show MIS-C Different from Severe COVID-19 in Children, Children's Hospital of Philadelphia

CHOP Researchers Show MIS-C Different from Severe COVID-19 in Children, Children's Hospital of Philadelphia

3 Aug 2020 9:23 AM | Anonymous

In the early days of the COVID-19 pandemic, the SARS-CoV-2 virus seemed only rarely to have serious complications in children. However, by April 2020, pediatricians had begun recognizing a syndrome in children who tested positive for COVID-19 involving hyperinflammation and some other attributes found in Kawasaki disease (KD). By May, the Centers for Disease Control and Prevention (CDC) had named the new condition Multisystem Inflammatory Syndrome in Children (MIS-C). Yet the biology of MIS-C and how it relates to or differs from severe COVID-19 in children has largely remained a mystery.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software